1.0 Overview: Purpose of this Document

The requirement to adhere to electronic submission guidance from the United States Food and Drug Administration (FDA) and the Japan Pharmaceuticals and Medical Devices Agency (PMDA) to submit data in a standardized Clinical Data Interchange Standards Consortium (CDISC) format is becoming critically important. ................
................